Green Thumb Industries Inc (GTBIF)
13.20
-0.16
(-1.20%)
USD |
OTCM |
May 03, 16:00
Green Thumb Industries Enterprise Value: 3.277B for May 3, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 03, 2024 | 3.277B |
May 02, 2024 | 3.314B |
May 01, 2024 | 3.281B |
April 30, 2024 | 3.786B |
April 29, 2024 | 3.122B |
April 26, 2024 | 3.044B |
April 25, 2024 | 2.945B |
April 24, 2024 | 3.111B |
April 23, 2024 | 3.039B |
April 22, 2024 | 2.994B |
April 19, 2024 | 3.080B |
April 18, 2024 | 3.213B |
April 17, 2024 | 3.255B |
April 16, 2024 | 3.092B |
April 15, 2024 | 3.111B |
April 12, 2024 | 3.170B |
April 11, 2024 | 3.478B |
April 10, 2024 | 3.424B |
April 09, 2024 | 3.533B |
April 08, 2024 | 3.537B |
April 05, 2024 | 3.466B |
April 04, 2024 | 3.265B |
April 03, 2024 | 3.663B |
April 02, 2024 | 3.675B |
April 01, 2024 | 3.663B |
Date | Value |
---|---|
March 28, 2024 | 3.589B |
March 27, 2024 | 3.703B |
March 26, 2024 | 3.507B |
March 25, 2024 | 3.341B |
March 22, 2024 | 3.445B |
March 21, 2024 | 3.466B |
March 20, 2024 | 3.253B |
March 19, 2024 | 3.336B |
March 18, 2024 | 3.352B |
March 15, 2024 | 3.201B |
March 14, 2024 | 2.890B |
March 13, 2024 | 2.876B |
March 12, 2024 | 2.783B |
March 11, 2024 | 2.869B |
March 08, 2024 | 3.018B |
March 07, 2024 | 2.904B |
March 06, 2024 | 2.986B |
March 05, 2024 | 3.182B |
March 04, 2024 | 3.191B |
March 01, 2024 | 3.240B |
February 29, 2024 | 3.122B |
February 28, 2024 | 3.168B |
February 27, 2024 | 3.229B |
February 26, 2024 | 3.383B |
February 23, 2024 | 3.533B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
889.79M
Minimum
Mar 16 2020
8.222B
Maximum
Feb 10 2021
3.281B
Average
2.727B
Median
Sep 19 2023
Enterprise Value Benchmarks
Flora Growth Corp | 15.64M |
Tilray Brands Inc | 1.854B |
Clever Leaves Holdings Inc | -2.630M |
Seelos Therapeutics Inc | 15.86M |
180 Life Sciences Corp | 0.7839M |
Enterprise Value Related Metrics
Net Income (Quarterly) | 3.216M |
Revenue (Quarterly) | 278.23M |
Total Expenses (Quarterly) | 227.89M |
EPS Diluted (Quarterly) | 0.01 |
Gross Profit Margin (Quarterly) | 51.28% |
Profit Margin (Quarterly) | 1.16% |
Earnings Yield | 1.14% |
Operating Earnings Yield | 5.85% |
Normalized Earnings Yield | 1.515 |